Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oncoustics has developed an AI-driven platform that analyzes raw ultrasound signals to non-invasively differentiate healthy from diseased tissues using novel acoustic biomarkers. Their "virtual biopsy" technology enables rapid point-of-care assessment for diseases with high unmet need. The company’s lead product, the OnX Liver Assessment Solution, has been introduced to over 70 clinics globally and FDA submissions are underway. Clinical data collection includes more than four million data points across multiple organ systems. Published studies include work in prostate cancer with Exact Imaging as a partner.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oncoustics.